Allogeneic stem cell transplantation for chronic myeloid leukemia

被引：41

作者：

Barrett, J ^{[1
]}

机构：

[1] NHLBI, Stem Cell Allotransplantat Sect, Hematol Branch, NIH, Bethesda, MD 20892 USA

来源：

SEMINARS IN HEMATOLOGY | 2003年 / 40卷 / 01期

关键词：

D O I：

10.1053/shem.2003.50003

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：59 / 71

页数：13

共 98 条

[1] Toxicity and efficacy of defined doses of CD4+ donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant [J].

Alyea, EP ;

Soiffer, RJ ;

Canning, C ;

Neuberg, D ;

Schlossman, R ;

Pickett, C ;

Collins, H ;

Wang, YL ;

Anderson, KC ;

Ritz, J .

BLOOD, 1998, 91 (10) :3671-3680

[2] Graft-versus-leukaemia [J].

Barrett, AJ ;

vanRhee, F .

BAILLIERES CLINICAL HAEMATOLOGY, 1997, 10 (02) :337-355

[3] Mechanisms of the graft-versus-leukemia reaction [J].

Barrett, AJ .

STEM CELLS, 1997, 15 (04) :248-258

[4] T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect [J].

Barrett, AJ ;

Mavroudis, D ;

Tisdale, J ;

Molldrem, J ;

Clave, E ;

Dunbar, C ;

Cottler-Fox, M ;

Phang, S ;

Carter, C ;

Okunnieff, P ;

Young, NS ;

Read, EJ .

BONE MARROW TRANSPLANTATION, 1998, 21 (06) :543-551

[5]

Barrett AJ, 2000, BLOOD, V95, P3323

[6] Remarkably reduced transplant-related complications by dibromomannitol non-myeloablative conditioning before allogeneic bone marrow transplantation in chronic myeloid leukemia [J].

Barta, A ;

Dénes, R ;

Masszi, T ;

Reményi, P ;

Bátai, A ;

Torbágyi, É ;

Sipos, A ;

Lengyel, L ;

Jakab, K ;

Gyódi, É ;

Réti, M ;

Földi, J ;

Páldi-Haris, P ;

Avalos, M ;

Pálóczi, K ;

Fekete, S ;

Török, J ;

Hoffer, I ;

Jakab, J ;

Váradi, G ;

Kelemen, E ;

Petrányi, G .

ACTA HAEMATOLOGICA, 2001, 105 (02) :64-70

[7] The adverse influence of pretransplant interferon-α (IFN-α) on transplant outcome after marrow transplantation for chronic phase chronic myelogenous leukemia increases with the duration of IFN-α exposure [J].

Beelen, DW ;

Elmaagacli, AH ;

Schaefer, UW .

BLOOD, 1999, 93 (05) :1779-1780

[8] Antileukemic effects of rapid cyclosporin withdrawal in patients with relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation [J].

Brandenburg, U ;

Gottlieb, D ;

Bradstock, K .

LEUKEMIA & LYMPHOMA, 1998, 31 (5-6) :545-550

[9]

Carreras E, 2000, HAEMATOLOGICA, V85, P530

[10] Harnessing graft-versus-malignancy: Non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy [J].

Champlin, R ;

Khouri, I ;

Shimoni, A ;

Gajewski, J ;

Kornblau, S ;

Molldrem, J ;

Ueno, N ;

Giralt, S ;

Anderlini, P .

BRITISH JOURNAL OF HAEMATOLOGY, 2000, 111 (01) :18-29

← 1 2 3 4 5 6 7 8 9 10 →